Browse
FDA applications
Approved and filed applications connected to their products and owning companies.
29,787 results
| Application | Applicant | Application number |
|---|---|---|
| BLA 761070 | AstraZeneca AB | BLA761070 |
| BLA 761071 | Sandoz Inc. | BLA761071 |
| BLA 761072 | Pfizer Ireland Pharmaceuticals Unlimited Company | BLA761072 |
| BLA 761073 | Amgen Inc. | BLA761073 |
| BLA 761074 | Biocon Biologics Inc. | BLA761074 |
| BLA 761075 | Biocon Biologics Inc. | BLA761075 |
| BLA 761077 | Amgen Inc. | BLA761077 |
| BLA 761078 | EMD SERONO INC | BLA761078 |
| BLA 761079 | BioMarin Pharmaceutical Inc. | BLA761079 |
| BLA 761080 | Hospira Inc., a Pfizer Company | BLA761080 |
| BLA 761081 | Pfizer Ireland Pharmaceuticals Unlimited Company | BLA761081 |
| BLA 761082 | Kashiv BioSciences, LLC | BLA761082 |
| BLA 761083 | Genentech, Inc. | BLA761083 |
| BLA 761084 | Kashiv BioSciences, LLC | BLA761084 |
| BLA 761085 | Evolus Inc. | BLA761085 |
| BLA 761086 | Amgen Inc. | BLA761086 |
| BLA 761088 | CELLTRION, Inc. | BLA761088 |
| BLA 761089 | Teva Branded Pharmaceutical Products R&D, Inc. | BLA761089 |
| BLA 761090 | Takeda Pharmaceuticals U.S.A., Inc. | BLA761090 |
| BLA 761091 | CELLTRION, Inc. | BLA761091 |
| BLA 761092 | Chiesi USA, Inc. | BLA761092 |
| BLA 761094 | Domp farmaceutici S.p.A. | BLA761094 |
| BLA 761097 | Regeneron Pharmaceuticals, Inc. | BLA761097 |
| BLA 761099 | Pfizer Inc. | BLA761099 |
| BLA 761100 | Samsung Bioepis Co., Ltd. | BLA761100 |
| BLA 761102 | Servier Pharmaceuticals LLC | BLA761102 |
| BLA 761103 | Pfizer Ireland Pharmaceuticals Unlimited Company | BLA761103 |
| BLA 761104 | AstraZeneca AB | BLA761104 |
| BLA 761105 | AbbVie Inc. | BLA761105 |
| BLA 761106 | Genentech, Inc. | BLA761106 |
| BLA 761107 | Swedish Orphan Biovitrum AB (publ) | BLA761107 |
| BLA 761108 | Alexion Pharmaceuticals, Inc. | BLA761108 |
| BLA 761109 | Eli Lilly and Company | BLA761109 |
| BLA 761111 | Hospira Inc., a Pfizer Company | BLA761111 |
| BLA 761112 | Ablynx NV | BLA761112 |
| BLA 761113 | Sanofi-Aventis U.S. LLC | BLA761113 |
| BLA 761115 | Gilead Sciences, Inc. | BLA761115 |
| BLA 761116 | Stemline Therapeutics, Inc. | BLA761116 |
| BLA 761118 | Pfizer Inc. | BLA761118 |
| BLA 761119 | Lundbeck Seattle BioPharmaceuticals, Inc. | BLA761119 |
| BLA 761121 | Genentech, Inc. | BLA761121 |
| BLA 761122 | GlaxoSmithKline LLC | BLA761122 |
| BLA 761123 | AstraZeneca AB | BLA761123 |
| BLA 761125 | Novartis Pharmaceuticals Corporation | BLA761125 |
| BLA 761126 | Tanvex BioPharma USA, Inc. | BLA761126 |
| BLA 761127 | Revance Therapeutics, Inc. | BLA761127 |
| BLA 761128 | Novartis Pharmaceuticals Corporation | BLA761128 |
| BLA 761133 | Takeda Pharmaceuticals U.S.A., Inc. | BLA761133 |
| BLA 761134 | Evive Biotechnology Singapore PTE. LTD. | BLA761134 |
| BLA 761136 | Celgene Corporation, a Bristol-Myers Squibb Company | BLA761136 |